Sensei Biotherapeutics Inc SNSE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:21 PM EDT
1.98quote price arrow down-0.07 (-3.41%)
Volume
42,977
52 week range
1.45 - 12.37
Loading...
  • Open2.10
  • Day High2.10
  • Day Low1.98
  • Prev Close2.05
  • 52 Week High12.37
  • 52 Week High Date09/09/21
  • 52 Week Low1.45
  • 52 Week Low Date05/16/22

Key Stats

  • Market Cap60.65M
  • Shares Out30.63M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-65.86

KEY STATS

  • Open2.10
  • Day High2.10
  • Day Low1.98
  • Prev Close2.05
  • 52 Week High12.37
  • 52 Week High Date09/09/21
  • 52 Week Low1.45
  • 52 Week Low Date05/16/22
  • Market Cap60.65M
  • Shares Out30.63M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-65.86

RATIOS/PROFITABILITY

  • EPS (TTM)-1.35
  • P/E (TTM)-1.47
  • Fwd P/E (NTM)-1.17
  • EBITDA (TTM)-41.079M
  • ROE (TTM)-26.90%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)1.95%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sensei Biotherapeutics Inc

There is no recent news for this security.

Profile

MORE
Sensei Biotherapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in the discovery and development of therapies with focus on treatments for cancer. Its ImmunoPhage platform is a self-adjuvanted and differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response. The Company is engineering its ImmunoPhage product candidates to directly target antigen...
William Ringo Jr.
Independent Chairman of the Board
John Celebi
President, Chief Executive Officer, Director
Erin Colgan
Chief Financial Officer
Address
620 Professional Drive
Gaithersburg, MD
20879
United States

Top Peers

SYMBOLLASTCHG%CHG
IMNM
Immunome Inc
4.69-0.38-7.51%
LTRN
Lantern Pharma Inc.
5.67+0.07+1.25%
QNCX
Quince Therapeutics Inc
2.14-0.07-3.23%
TYME
Tyme Technologies Inc
0.3051-0.0187-5.7752%
ATXS
Astria Therapeutics Inc
5.20-0.01-0.19%